Digital Look

Welcome to Digital Look++,
you are not logged in

Midatech Pharma (MTPH)

Pharma and Biotech

1.95p

Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-17	0.99	(12.97)	(453.23)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-18	1.94	(12.40)	(6,680.25)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-19	0.67	(10.92)	(1,000.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	0.34	(23.47)	(52.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	0.58	(6.11)	(7.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Second Price Monitoring Extn	23-Jan-2023	16:40	RNS
Price Monitoring Extension	23-Jan-2023	16:35	RNS
Result of General Meeting	23-Jan-2023	12:00	RNS

Midatech taps Stephen Parker as its new chairman	10-Jun-2022	ShareCast
Midatech extends work with Janssen to another ex...	09-Mar-2022	ShareCast
Midatech Pharma interim losses narrow	17-Sep-2021	ShareCast

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.